The Inhibitory Effect of Selenium Supplementation on Tumor Progression in a DMBA-Induced Breast Cancer Model in Wistar Rats

Background: Breast cancer remains a significant global public health concern, necessitating the ongoing exploration of novel preventive and therapeutic strategies. Selenium supplementation has been proposed as a potential chemopreventive agent, yet its efficacy lacks robust in vivo validation.

Aims: This study aimed to evaluate the chemopreventive potential of selenium supplementation and its effect on tumor progression in a 7,12-dimethylbenz[a]anthracene DMBA-induced breast cancer model in Wistar rats. 

Methods: Twenty-four adult female Wister rat were allocated into four experimental groups (n=6): Control (vehicle only); DMBA (carcinogen control); DMBA + Se 200 µg/kg; and DMBA + Se 400 µg/kg. Mammary tumors were induced via a single intragastric administration of DMBA (80 mg/kg). Over a 23-week period, hematological, biochemical, and histopathological analyses were conducted. The volume of excised mammary tumors was measured post-sacrifice.

Results: Supplementation with selenium at a dose of 400 µg/kg resulted in a statistically significant reduction in mean tumor volume (0.13 cm³) compared to the DMBA-only group (1.32 cm³). Concurrently, this high-dose group exhibited significant amelioration in serum levels of specific biochemical markers including aspartate aminotransferase (AST), urea, and creatinine. Histopathological assessment further supported these findings, revealing a more preserved mammary tissue architecture in rats receiving the high-dose selenium.

Conclusions: While selenium supplementation at 400 µg/Kg demonstrated a significant inhibition effect on tumor progression and conferred hepatorenal protection, a definitive chemopreventive effect against DMBA-induced carcinogenesis was not established. These results indicate that selenium may function as a therapeutic modulator rather than a primary preventive agent in this model. Further investigation employing higher doses and alternative administration regimens is warranted to elucidate its full chemopreventive potential.

Keywords

Breast cancer Selenium DMBA Chemoprevention Tumor Progression Wistar rats
  • Nour EL-Houda Feriel Djebara
    Laboratory Research on Biological Systems and Geomatics, Faculty of Nature and Life, University of Mascara.
  • Adel Gouri
    Laboratory of Biochemistry, Faculty of Medicine, Badji Mokhtar University, Annaba, Algeria.
  • Houari Hemida
    Department of Biomedicine, Institute of veterinary sciences, University of Tiaret, Algeria.
  • Chahinaise Zaoui
    Laboratory of Developmental Biology and Differentiation. Faculty of Natural and Life Sciences, ORAN 1 University and Department of Pharmacy, Faculty of Medicine, Oran 1 University.
  • Bachir Benarba
    Laboratory Research on Biological Systems and Geomatics, Faculty of Nature and Life, University of Mascara, Algeria

How to Cite

The Inhibitory Effect of Selenium Supplementation on Tumor Progression in a DMBA-Induced Breast Cancer Model in Wistar Rats. (2025). The North African Journal of Food and Nutrition Research, 9(20), 112-122. https://doi.org/10.51745/najfnr.9.20.112-122

Akhouri, V., Kumari, M., & Kumar, A. (2020). Therapeutic effect of Aegle marmelos fruit extract against DMBA induced breast cancer in rats. Scientific Reports, 10(1), 18016. https://doi.org/10.1038/s41598-020-72935-2

Baltaci, S. B., Mogulkoc, R., Baltaci, A. K., Emsen, A., & Artac, H. (2018). The effect of zinc and melatonin supplementation on immunity parameters in breast cancer induced by DMBA in rats. Archives of Physiology and Biochemistry, 124(3), 247–252. https://doi.org/10.1080/13813455.2017.1392580

Cai, X., Wang, C., Yu, W., Fan, W., Wang, S., Shen, N., Wu, P., Li, X., & Wang, F. (2016). Selenium exposure and cancer risk: An updated meta-analysis and meta-regression. Scientific Reports, 6(1), 19213. https://doi.org/10.1038/srep19213

Cardoso, B. R., Roberts, B. R., Bush, A. I., & Hare, D. J. (2015). Selenium, selenoproteins and neurodegenerative diseases. Metallomics. Integrated Biometal Science, 7(8), 1213–1228. https://doi.org/10.1039/c5mt00075k

Çay, M., & Naziroğlu, M. (1999). Effects of intraperitoneally-administered vitamin E and selenium on the blood biochemical and haematological parameters in rats. Cell Biochemistry and Function, 17(2), 143-148. https://doi.org/10.1002/(sici)1099-0844(199906)17:2<143::aid-cbf802>3.0.co;2-h

Charalabopoulos, K., Kotsalos, A., Batistatou, A., Charalabopoulos, A., Vezyraki, P., Peschos, D., Kalfakakou, V., & Evangelou, A. (2006). Selenium in serum and neoplastic tissue in breast cancer: correlation with CEA. British Journal of Cancer, 95(6), 674–676. https://doi.org/10.1038/sj.bjc.6603292

Cinato, M., Andersson, L., Miljanovic, A., Laudette, M., Kunduzova, O., Borén, J., & Levin, M. C. (2024). Role of perilipins in oxidative stress-implications for cardiovascular disease. Antioxidants (Basel, Switzerland), 13(2), 209. https://doi.org/10.3390/antiox13020209

El-Bayoumy, K. (2001). The protective role of selenium on genetic damage and on cancer. Mutation Research, 475(1–2), 123–139. https://doi.org/10.1016/s0027-5107(01)00075-6

El makawy, A. I., Mabrouk, D. M., Mohammed, S. E., Abdel-Aziem, S. H., EL-Kader, H. A. A., Sharaf, H. A., Youssef, D. A., & Ibrahim, F. M. (2022). The suppressive role of nanoencapsulated chia oil against DMBA-induced breast cancer through oxidative stress repression and tumor genes expression modulation in rats. Molecular Biology Reports, 49(11), 10217–10228. https://doi.org/10.1007/s11033-022-07885-1

Elen, A., & Turan, M. K. (2019). Classifying white blood cells using machine learning algorithms. Uluslararası Muhendislik Arastirma ve Gelistirme Dergisi, 141–152. https://doi.org/10.29137/umagd.498372

Similar Articles

1-10 of 27

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)

Downloads 274

-

Views 678

-

Country (Top 10)